Literature DB >> 16684211

Albumin regeneration in liver support-comparison of different methods.

Steffen Mitzner1, Sebastian Klammt, Jan Stange, Reinhart Schmidt.   

Abstract

Albumin is the most abundant human plasma protein. Among many other functions it is an important transporter of hydrophobic internal and external substances such as intermediate and end products of metabolism and drugs. In liver failure the albumin binding capacity is decreased because of a disproportion between available albumin molecules caused by decreased hepatic synthesis and hydrophobic toxins because of decreased hepatic clearance. The resulting increase in plasma and tissue concentrations of these substances is associated with multiple organ dysfunctions frequently seen in severe liver failure. The scope of the present article is to compare different liver support strategies with regard to their ability to regenerate the patients albumin pool by removing albumin-bound toxins. Most prominent technique in this group is the molecular adsorbent recirculating system (MARS). It will be compared with single pass albumin dialysis (SPAD), fractionated plasma separation and adsorption system (FPSA, Prometheus), and plasma perfusion/bilirubin adsorption with special regard to efficacy and selectivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684211     DOI: 10.1111/j.1744-9987.2006.00351.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  8 in total

Review 1.  Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.

Authors:  Valentin Fuhrmann; Bernhard Jäger; Anna Zubkova; Andreas Drolz
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

2.  Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary center.

Authors:  Ya-Wen Yang; Che-Hsiung Wu; Rey-Heng Hu; Ming-Chin Ho; Meng-Kun Tsai; Yao-Ming Wu; Po-Huang Lee
Journal:  Hepatol Int       Date:  2010-05-19       Impact factor: 6.047

3.  Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report.

Authors:  Katherine L Collins; Eve A Roberts; Khosrow Adeli; Desmond Bohn; Elizabeth A Harvey
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

4.  Standardized intensive care unit management in an anhepatic pig model: new standards for analyzing liver support systems.

Authors:  Christian Thiel; Karolin Thiel; Alexander Etspueler; Thomas Schenk; Matthias H Morgalla; Alfred Koenigsrainer; Martin Schenk
Journal:  Crit Care       Date:  2010-07-22       Impact factor: 9.097

5.  Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study.

Authors:  Jens Altrichter; Martin Sauer; Katharina Kaftan; Thomas Birken; Doris Gloger; Martin Gloger; Jörg Henschel; Heiko Hickstein; Ernst Klar; Sebastian Koball; Annette Pertschy; Gabriele Nöldge-Schomburg; Dierk A Vagts; Steffen R Mitzner
Journal:  Crit Care       Date:  2011-03-03       Impact factor: 9.097

6.  Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering.

Authors:  Hussamuddin Adwan; Barry Fuller; Clare Seldon; Brian Davidson; Alexander Seifalian
Journal:  J Biomater Appl       Date:  2012-04-24       Impact factor: 2.646

Review 7.  Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications.

Authors:  Gianluca Villa; Mauro Neri; Rinaldo Bellomo; Jorge Cerda; A Raffaele De Gaudio; Silvia De Rosa; Francesco Garzotto; Patrick M Honore; John Kellum; Anna Lorenzin; Didier Payen; Zaccaria Ricci; Sara Samoni; Jean-Louis Vincent; Julia Wendon; Marta Zaccaria; Claudio Ronco
Journal:  Crit Care       Date:  2016-10-10       Impact factor: 9.097

8.  Evaluation of blood metabolites reflects presence or absence of liver abscesses in beef cattle.

Authors:  Alaina G C Macdonald; Stéphanie L Bourgon; Rupert Palme; Stephen P Miller; Yuri R Montanholi
Journal:  Vet Rec Open       Date:  2017-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.